Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
<br><strong>Purpose: </strong>In current radiotherapy (RT) planning and delivery, population-based dose-volume constraints are used to limit the risk of toxicity from incidental irradiation of organs at risks (OARs). However, weighing tradeoffs between target coverage and doses to...
第一著者: | Aznar, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Taylor & Francis
2020
|
類似資料
-
On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning
著者:: Linda Rossi, 等
出版事項: (2021-04-01) -
Advanced Radiotherapy Techniques for Mediastinal Lymphomas: Results from an Italian Survey
著者:: Anna Di Russo, 等
出版事項: (2021-08-01) -
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma
著者:: Loic Renaud, 等
出版事項: (2024-05-01) -
Radiotherapy after immunochemotherapy improves outcomes in patients with primary mediastinal large B‐cell lymphoma
著者:: Agustin Avilés, 等
出版事項: (2019-12-01) -
Linfoma mediastinal en una lactante Mediastinal lymphoma in an infant
著者:: Delfín Chaveco Bautista, 等
出版事項: (2010-01-01)